Profiled hemodialysis reduces intradialytic symptoms

Area of Science:

• Nephrology
• Clinical Medicine
• Dialysis Technology

Background:

• Intradialytic symptoms are common complications during hemodialysis.
• Symptoms such as hypotension, muscle cramps, and dizziness negatively impact patient well-being and treatment adherence.
• Standard hemodialysis protocols are associated with a significant incidence of these adverse effects.

Purpose of the Study:

• To evaluate the efficacy of profiled hemodialysis in mitigating intradialytic symptoms.
• To assess the impact of combined sodium and ultrafiltration profiling on patient-reported symptoms.
• To compare the effectiveness of different profiling modes.

Main Methods:

• Prospective study involving patients undergoing hemodialysis between September and December 2002.
• Patients experiencing symptoms were assigned to specific sodium and ultrafiltration profiling modes on Fresenius MC 4008 H&E machines.
• Symptom evaluation (hypotension, muscle cramps, dizziness, headache, nausea, discomfort, thirst, shortness of breath) was conducted before and at 2, 4, and 6 weeks after initiating profiled hemodialysis.

Main Results:

• On standard hemodialysis, 36.4% of patients reported symptoms, with hypotension (72.5%), dizziness (55%), headache (37.5%), and muscle cramps (22.5%) being most frequent.
• Profiled hemodialysis led to significant improvements (P <.05) in these symptoms at 2, 4, and 6 weeks.
• No significant differences were observed between the different applied profiling modes.
• Other symptoms like nausea and thirst were infrequently reported.

Conclusions:

• Sodium and ultrafiltration profiling are effective in reducing acute adverse effects during hemodialysis.
• Profiled hemodialysis enhances patient well-being and improves dialysis tolerance.
• This technique minimizes the need for interventions during dialysis sessions.